MedTrace Logo

Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET

NCT03809689 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-06-20

No results posted yet for this study

Summary

The study is about exploring physiological angiogenesis linked to tissue repair in patients with acute heart infarction or chronic heart ischemia by means of 68Ga-NODAGA-RGD PET/CT imaging.

Conditions

  • Myocardial Infarction, Acute
  • Myocardial Reperfusion
  • Chronic Ischemic Heart Disease

Interventions

OTHER

68Ga-NODAGA-RGD PET/CT

intravenous injection of 200 Megabecquerel (MBq) 68Ga-NODAGA-RGD followed by a whole-body acquisition after injection and one hour after injection

DIAGNOSTIC_TEST

82-Rb PET/CT as part of standard care, not a comparator

2 intravenous injections of standard dose of 82-Rb : the first followed by an at-rest acquisition, the second followed by a pharmacological myocardial stress acquisition

Sponsors & Collaborators

  • University of Lausanne Hospitals

    lead OTHER

Principal Investigators

  • John O Prior, PhD, MD · University of Lausanne Hospitals

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2023-09-01
Completion
2023-10-11

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03809689 on ClinicalTrials.gov